Inpatient palliative chemotherapy is associated with high mortality and aggressive end-of-life care in patients with advanced solid tumors and poor performance status
Abstract Background The benefit of palliative chemotherapy (PC) in patients with advanced solid tumors and poor performance status (ECOG-PS) has not been prospectively validated, which makes treatment decision challenging. We aimed to evaluate the overall survival, factors associated with early mort...
Main Authors: | Vitor Fiorin de Vasconcellos, Renata RCC Bonadio, Guilherme Avanço, Marcelo Vailati Negrão, Rachel Pimenta Riechelmann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | BMC Palliative Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12904-019-0427-4 |
Similar Items
-
End-of-life palliative chemotherapy: Where do we stand?
by: Amrallah A. Mohammed, et al.
Published: (2015-03-01) -
Aggressive surgical palliation for advanced girdle tumours
by: Andrew Burd, et al.
Published: (2012-01-01) -
Palliation, end-of-life care and burns; concepts, decision-making and communication – A narrative review
by: Daan den Hollander, et al.
Published: (2020-06-01) -
Futile Medication in Palliative Cancer Patients; a Report from the Middle East
by: Hamed Mahzoni, et al.
Published: (2023-04-01) -
Inappropriate hemodialysis treatment and palliative care
by: Novotný Rudolf, et al.
Published: (2020-06-01)